UpdatesGeneral Updates
Cohance Lifesciences' USFDA inspection at its Hyderabad facility concluded with five observations.
Cohance Lifesciences LimitedCOHANCE · Filed with the exchange
Importantly, none relate to data integrity issues.
The company is preparing corrective actions and expects timely resolution of these observations.
No comments yet. Be the first.